These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11313269)

  • 1. Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia.
    Harrison BD; Adams JA; Briggs M; Brereton ML; Yin JA
    Blood; 2001 May; 97(9):2764-71. PubMed ID: 11313269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
    Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
    Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The T cells activated by dendritic cells derived from AML cells: a study of their cytotoxic effect on autologous AML cells].
    Xiang B; Li SF; Zhou J; Mao YQ; Yang YM; Liu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):784-7. PubMed ID: 15573754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
    Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
    Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34+ hematopoietic progenitor cells: induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients.
    Fujii S; Fujimoto K; Shimizu K; Ezaki T; Kawano F; Takatsuki K; Kawakita M; Matsuno K
    Cancer Res; 1999 May; 59(9):2150-8. PubMed ID: 10232602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
    Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
    J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses.
    Choudhury BA; Liang JC; Thomas EK; Flores-Romo L; Xie QS; Agusala K; Sutaria S; Sinha I; Champlin RE; Claxton DF
    Blood; 1999 Feb; 93(3):780-6. PubMed ID: 9920826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro stimulation of specific antileukemia T-cell response by dendritic cells derived from CD14+ acute monocytic leukemia cells].
    Sheng LX; Xie XB; Qiu GQ; Gu WY; Wang ZL; Wu HQ
    Ai Zheng; 2005 Nov; 24(11):1338-44. PubMed ID: 16552959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia.
    Choudhury A; Gajewski JL; Liang JC; Popat U; Claxton DF; Kliche KO; Andreeff M; Champlin RE
    Blood; 1997 Feb; 89(4):1133-42. PubMed ID: 9028934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient generation of antileukemic autologous T cells by short-term culture and gamma-irradiation of myeloid leukemic cells.
    Vereecque R; Saudemont A; Depil S; Corm S; Andrieux J; Soenen-Cornu V; Quesnel B
    Cancer Immunol Immunother; 2004 Sep; 53(9):793-8. PubMed ID: 15098140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of cryopreservation on leukemic dendritic cells derived from leukemia patients].
    Huang YZ; Shen JL; Wang LX; Xiang D; Zheng PH; Cen J; Gong LZ; Liu Y; Yang PD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):873-7. PubMed ID: 17708823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential modulation of growth factors: a novel strategy for adoptive immunotherapy of acute myeloid leukemia.
    Zhong RK; Rassenti LZ; Kipps TJ; Chen J; Law P; Yu JF; Ball ED
    Biol Blood Marrow Transplant; 2002; 8(10):557-68. PubMed ID: 12434951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-free culture of dendritic cells from patients with chronic myeloid leukemia in vitro and estimation of their cytotoxicity.
    Zhao W; Xing P; Wei X; Wang T; Yang D; Li M
    Chin Med J (Engl); 2002 Sep; 115(9):1296-300. PubMed ID: 12411098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting effects on the induction of cytotoxic T lymphocytes by dendritic cells pulsed with lysates from acute myeloid leukemia blasts.
    Schui DK; Singh L; Schneider B; Knau A; Hoelzer D; Weidmann E
    Leuk Res; 2002 Apr; 26(4):383-9. PubMed ID: 11839382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Li L; Schmitt A; Reinhardt P; Greiner J; Ringhoffer M; Vaida B; Bommer M; Vollmer M; Wiesneth M; Döhner H; Schmitt M
    Cancer Immun; 2003 Jul; 3():8. PubMed ID: 12862419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience.
    Bagheri K; Alimoghadam K; Pourfathollah AA; Hassan ZM; Hajati J; Moazzeni SM
    Pathol Oncol Res; 2009 Jun; 15(2):257-67. PubMed ID: 18807213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts.
    Li L; Giannopoulos K; Reinhardt P; Tabarkiewicz J; Schmitt A; Greiner J; Rolinski J; Hus I; Dmoszynska A; Wiesneth M; Schmitt M
    Int J Oncol; 2006 Apr; 28(4):855-61. PubMed ID: 16525634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Interferon (IFN)α in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions.
    Hirn Lopez A; Deen D; Fischer Z; Rabe A; Ansprenger C; Stein K; Vogt V; Schick J; Kroell T; Kraemer D; Kolb HJ; Tischer J; Schmid C; Schmetzer H
    J Immunother; 2019 Jun; 42(5):143-161. PubMed ID: 31090655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia.
    Woiciechowsky A; Regn S; Kolb HJ; Roskrow M
    Leukemia; 2001 Feb; 15(2):246-55. PubMed ID: 11236940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.